摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

多佐胺-2-3 | 148719-91-9

中文名称
多佐胺-2-3
中文别名
(6S)-5,6-二氢-6-甲基-4H-噻吩并[2,3-b]噻喃-4-酮7,7-二氧化物多佐胺-2-3;(6S)-5,6-二氢-6-甲基-4H-噻吩并[2,3-b]噻喃-4-酮 7,7-二氧化物;(6S)-5,6-二氢-6-甲基-4H-噻吩并(2,3-b)噻喃-4-酮-7,7-二氧化物
英文名称
(S)-5,6-dihydro-6-methylthieno<2,3-b>thiopyran-4-one 7,7-dioxide
英文别名
(6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one-7,7-dioxide;(S)-6-Methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide;(6S)-6-methyl-7,7-dioxo-5,6-dihydrothieno[2,3-b]thiopyran-4-one
多佐胺-2-3化学式
CAS
148719-91-9
化学式
C8H8O3S2
mdl
——
分子量
216.282
InChiKey
LQUUXMUPBQBKHA-YFKPBYRVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    441.9±45.0 °C(Predicted)
  • 密度:
    1.453

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    87.8
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:26a65d08e17b6b22f80ba6aa950bd585
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    多佐胺-2-3 在 sodium tetrahydroborate 作用下, 以 甲醇二氯甲烷甲苯 为溶剂, 以84%的产率得到多佐胺-2-4
    参考文献:
    名称:
    Process for obtaining 4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide and its enantiomers, and applications thereof
    摘要:
    该发明涉及一种通过用产生氢化物离子的还原剂还原5,6-二氢-6-甲基-4H-噻吩[2,3-b]噻吩吡喃-4-酮-7,7-二氧化物,从而获得顺式-4-羟基-6-甲基-5,6-二氢-4H-噻吩[2,3-b]噻吩吡喃-7,7-二氧化物,其对映体或其混合物的过程。所得化合物在手性活性成分合成中作为中间体有用。
    公开号:
    EP2128161A1
  • 作为产物:
    描述:
    多佐胺-2-2 在 sodium tungstate (VI) dihydrate 、 双氧水 作用下, 以 乙酸乙酯甲苯 为溶剂, 以80%的产率得到多佐胺-2-3
    参考文献:
    名称:
    Process for obtaining 4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide and its enantiomers, and applications thereof
    摘要:
    该发明涉及一种通过用产生氢化物离子的还原剂还原5,6-二氢-6-甲基-4H-噻吩[2,3-b]噻吩吡喃-4-酮-7,7-二氧化物,从而获得顺式-4-羟基-6-甲基-5,6-二氢-4H-噻吩[2,3-b]噻吩吡喃-7,7-二氧化物,其对映体或其混合物的过程。所得化合物在手性活性成分合成中作为中间体有用。
    公开号:
    EP2128161A1
点击查看最新优质反应信息

文献信息

  • Process for obtaining 4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide and its enantiomers, and applications thereof
    申请人:Ragactives, S.L.
    公开号:EP2128161A1
    公开(公告)日:2009-12-02
    The invention relates to a process for obtaining cis-4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide, its enantiomers or mixtures thereof, by reduction of 5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one-7,7-dioxide with a reducing agent which generates hydride ions. The obtained compounds are useful as intermediates in the synthesis of chiral active ingredients.
    该发明涉及一种通过用产生氢化物离子的还原剂还原5,6-二氢-6-甲基-4H-噻吩[2,3-b]噻吩吡喃-4-酮-7,7-二氧化物,从而获得顺式-4-羟基-6-甲基-5,6-二氢-4H-噻吩[2,3-b]噻吩吡喃-7,7-二氧化物,其对映体或其混合物的过程。所得化合物在手性活性成分合成中作为中间体有用。
  • Process for Preparing Enantiomerically Enriched Oxamides
    申请人:Zach System S.P.A.
    公开号:US20150191485A1
    公开(公告)日:2015-07-09
    The present invention relates to a chiral oxamide of formula (I) useful as an intermediate in the preparation of dorzolamide, and to the preparation thereof. The invention also relates to the preparation of dorzolamide, to the hydrochloride salt thereof, and to the active ingredient contained in a drug useful in the treatment of glaucoma, by means of the intermediate of formula (I).
    本发明涉及一种手性酰胺,其化学式为(I),可用作多索胺制备中间体,并涉及其制备方法。该发明还涉及多索胺的制备,其盐酸盐,以及通过化学式(I)的中间体制备用于治疗青光眼的药物中所含的活性成分。
  • [EN] ASYMMETRIC REDUCTION PROCESS<br/>[FR] PROCÉDÉ DE RÉDUCTION ASYMÉTRIQUE
    申请人:ZACH SYSTEM SPA
    公开号:WO2012120086A1
    公开(公告)日:2012-09-13
    The present invention relates to a stereoselective reduction procedure to obtain, by means of catalytic asymmetric hydrogenation by hydrogen transfer, a compound of formula (I) in which X is S or SO2 and R4 is hydrogen or an SO2NH2 group, from the corresponding ketone precursor, said compound of formula (I) being useful as an intermediate in the preparation of dorzolamide or of the hydrochloride salt thereof.
    本发明涉及一种立体选择性还原程序,通过氢转移的催化不对称加氢,得到一种化合物,其化学式为(I),其中X为S或SO2,R4为氢或SO2NH2基团,从相应的酮前体中获得。所述化合物的化学式(I)可作为多索胺或其盐的盐酸盐的制备中间体。
  • Process for preparing thienothiopyran derivative
    申请人:Kanegafuchi Kagaku Kogyo Kabushiki Kaisha
    公开号:US05565345A1
    公开(公告)日:1996-10-15
    A process for preparing 5,6-dihydro-4-hydroxy-(S)-6-methyl-thieno[2,3-b]thiopyran-7,7-dioxide having the formula (II): ##STR1## which comprises subjecting 5,6-dihydro-4-oxo-(S)-6-methyl-thieno[2,3-b]thiopyran-7,7-dioxide having the formula (I): ##STR2## to the action of a microorganism to reduce the thienothiopyran derivative having the formula (I), and collecting 5,6-dihydro-4-hydroxy-(S)-6-methyl-thieno-[2,3-b]thiopyran-7,7-dioxide having the formula (II) from the reaction mixture, wherein said microorganism belongs to the genus selected from the group consisting of Ambrosiozyma, Arthroascus, Ashbya, Candida, Cryptococcus, Hansenula, Kluyveromyces, Lipomyces, Lodderomyces, Metschnikowia, Pachysolen, Pichia, Rhodosporidium, Rhodotorula, Saccharomyces, Saccharomycopsis, Schwanniomyces, Sporidiobolus, Spolobolomyces, Stephanoascus, Trigonopsis, Trichosporon and Wingea, according to which, a simple and effective. process for preparing 5,6-dihydro-4-hydroxy-(S)-6-methyl-thieno-[2,3-b]thiopyran-7,7-dioxide.
    一种制备式(II)的5,6-二氢-4-羟基-(S)-6-甲基噻吩[2,3-b]噻吩吡喃-7,7-二氧化物的工艺,包括将式(I)的5,6-二氢-4-氧代-(S)-6-甲基噻吩[2,3-b]噻吩吡喃-7,7-二氧化物暴露于微生物作用下以还原式(I)的噻吩噻吩吡喃衍生物,并从反应混合物中收集式(II)的5,6-二氢-4-羟基-(S)-6-甲基噻吩[2,3-b]噻吩吡喃-7,7-二氧化物,其中所述微生物属于以下组中所选的属:Ambrosiozyma、Arthroascus、Ashbya、Candida、Cryptococcus、Hansenula、Kluyveromyces、Lipomyces、Lodderomyces、Metschnikowia、Pachysolen、Pichia、Rhodosporidium、Rhodotorula、Saccharomyces、Saccharomycopsis、Schwanniomyces、Sporidiobolus、Spolobolomyces、Stephanoascus、Trigonopsis、Trichosporon和Wingea,因此,提供了一种简单有效的制备5,6-二氢-4-羟基-(S)-6-甲基噻吩[2,3-b]噻吩吡喃-7,7-二氧化物的工艺。
  • ASYMMETRIC REDUCTION PROCESS
    申请人:Volpicelli Raffaella
    公开号:US20130338377A1
    公开(公告)日:2013-12-19
    The present invention relates to a stereoselective reduction procedure to obtain, by means of catalytic asymmetric hydrogenation by hydrogen transfer, a compound of formula (I) in which X is S or SO 2 and R 4 is hydrogen or an SO 2 NH 2 group, from the corresponding ketone precursor, said compound of formula (I) being useful as an intermediate in the preparation of dorzolamide or of the hydrochloride salt thereof.
    本发明涉及一种立体选择性还原程序,通过氢转移的催化不对称氢化反应,从相应的酮前体中得到式(I)的化合物,其中X为S或SO2,R4为氢或SO2NH2基团,所述式(I)的化合物在多索胺或其盐的制备中作为中间体有用。
查看更多